External reports (aggregated public sources), Value Investors Club

Value Investors Club

Value Investors Club (.com) is an exclusive online investment club where top investors share their best ideas. Content available at the above link/PDF preview is an external article authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>SPRB is developing tildacerfont, a second-generation CRF1 antagonist for CAH treatment</li><li>Recent Phase 2 trial failure doesn't negate potential, but upcoming trial results are more relevant</li><li>Market overreaction to negative news creates attractive opportunity for investors, with upside potential and downside protection for SPRB</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

SPRB is developing tildacerfont, a second-generation CRF1 antagonist for CAH treatmentRecent Phase 2 trial failure doesn't negate potential, but upcoming trial results are more relevantMarket overreaction to negative news creates attractive opportunity for investors, with upside potential and downside protection for SPRBThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Spruce Biosciences Inc (SPRB) - Friday, Mar 22, 2024